Design, characterization and quantum chemical computations of a novel series of pyrazoles derivatives with potential anti-proinflammatory response
MetadataShow full item record
The synthesis and characterization of the full family of 11 pyrazoles were performed by means of UV–Vis, FTIR, 1H NMR, 13C NMR, two-dimensional NMR experiments and DFT simulations. As pyrazoles are known for showing diverse biological actions, they were also tested in the NCI-60 cancer cell line panel, showing moderate to good activity against different cell lines. Furthermore, the anti-proinflammatory activity test of a set of pyrazoles of the form (E)-4-((4-bromophenyl)diazenyl)-3,5-dimethyl-1-R-phenyl-1H-pyrazole was performed, this is based on the study of the blockage of the increase in intracellular [Ca2+] observed in response to platelet-activating factor (PAF) treatment of four pyrazoles (i.e. 6, 8, 9 and 10), which successfully displayed [Ca2+] channel inhibition. Therefore, the obtained intracellular [Ca2+] signal results indicate that the pyrazole family characterized in this study, in particular compounds 6 and 10, are potent blockers of the PAF-initiated Ca2+ signaling that mediates the hyperpermeability typically observed during the development of inflammation. © 2020 The Author(s)
Showing items related by title, author, creator and subject.
Tuning the molecular/electronic structure of new substituted pyrazoles: Synthesis, biological trials, theoretical approaches and Hammett correlations (2020) Bustos C.; Alvarez-Thon L.; Molins E.; Moreno-Villoslada I.; Vallejos-Contreras G.; Sánchez C.; Zarate X.; Mac-Leod Carey D.; Schott E. (Elsevier B.V., 2018)
Synthesis, characterization, spectroscopic properties and DFT study of a new pyridazinone family (2020) Arrue L.; Rey M.; Rubilar-Hernandez C.; Correa S.; Molins E.; Norambuena L.; Zarate X.; Schott E. (Elsevier B.V., 2017)
ArticleFaúndez R.; Castillo F.; Preite M.; Schott E.; Zarate X.; Manriquez J.M.; Molins E.; Morales-Verdejo C.; Chávez I. (Georg Thieme Verlag, 2019)